Executive MBA Convocation

The livestream can be viewed from this page on Saturday, December 11th starting at 2:00pm (Central Time, GMT-6).
If you do not see the stream at that time, please refresh the page.

Congratulations, Cohorts 122 & 123. We applaud you.

---

Saturday, December 11th at 2:00 PM (CT)

• Processional
  Graduates and Faculty
• Faculty and Students Welcome
  Greg Hanifee
  Associate Dean, Degree Program Operations
• Opening Remarks
  Francesca Cornelli
  Dean, Kellogg School of Management
• Introduction of Convocation Speaker
  Bernadette Birt
  Assistant Dean, Executive MBA Global Network
• Convocation Address
  Milton M. Morris ’92, ’04
• Introduction of Graduates
  Colette Feldges
  Director, Executive MBA Program, Evanston
  
  Steven Thompson
  Director, Executive MBA Program, Miami
• Recessional
  Faculty
• Reception
  Drake Hotel, Chicago

---

Keynote Speaker

Milton M. Morris ’92, ’04

MILTON M. MORRIS, Ph.D. joined Neuspera Medical, a Clinical Stage Privately held company, as its President and CEO in July of 2015. Since then, Dr. Morris has led 3 successful institutional rounds of financing enabling the Neuspera program to experience steady growth and initial commercial approval of its ultraminiaturized neurostimulators. Prior to joining Neuspera, Milton was the Sr. Vice President of Research & Development and Emerging Therapies at Cyberonics (now LivaNova) where he assembled and led an R&D team that pioneered the first closed-loop vagus nerve stimulation device for Epilepsy. Dr. Morris was employed by Guidant Corporation and its successor, Boston Scientific Corporation. During his tenure, he held several positions of increasing responsibility within Research & Development and Sales & Marketing where he served as the Arrhythmia Franchise leader with responsibilities for both the implantable pacemaker and defibrillator businesses for the Cardiac Rhythm Management division of Boston Scientific. Prior to joining Guidant, Dr. Morris spent 5 years working as a Research Assistant in the Medical Computing Laboratory at the University of Michigan in collaboration with the electrophysiology group at the University of Michigan hospital and the Michigan Heart and Vascular Institute. During this period, Dr. Morris was awarded fellowships from the National Science Foundation (NSF) and the National Institutes of Health (NIH) in support of his research on the development of novel approaches to low power arrhythmia classification algorithms designed for implantable defibrillators. Dr. Morris is named as an inventor on over 30 patents, and an author on 20 peer-reviewed publications, book chapters, abstracts, and scientific presentations.

Dr. Morris is a Fellow in the American Institute for Medical and Biological Engineering (AIMBE) where he was inducted for contributions to developing and commercializing innovations in bioelectronic medicine.

Dr. Morris holds a Master’s in business administration from the Kellogg School of Management, a Master’s and Ph.D. in Electrical Engineering from the University of Michigan and a Bachelor of Science in Electrical Engineering from Northwestern University.

---